APLT
Applied Therapeutics Inc
NASDAQ: APLT · HEALTHCARE · BIOTECHNOLOGY
$0.10
+0.00% today
Updated 2026-04-29
Market cap
$14.86M
P/E ratio
—
P/S ratio
14.86x
EPS (TTM)
$-0.10
Dividend yield
—
52W range
$0 – $2
Volume
2.7M
Applied Therapeutics Inc (APLT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.19M | $-11.18M | $-36.31M | $-78.21M | $-90.73M | $-78.09M | $-55.17M | $-84.31M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | $23000.00 | $23000.00 | $23000.00 | $380000.00 | $415000.00 | $443000.00 | $354000.00 | $425000.00 |
| Stock-based comp | $32000.00 | $272000.00 | $6.17M | $8.03M | $11.18M | $9.60M | $7.36M | $13.47M |
| Free cash flow | $-3.19M | $-11.18M | $-36.31M | $-78.21M | $-90.73M | $-78.09M | $-55.17M | $-84.31M |
| Investing cash flow | $-20.01M | $-20.01M | $-20.01M | $-19.47M | $12.43M | $13.17M | $13.87M | — |
| Financing cash flow | $6.47M | $26.65M | $56.41M | $136.29M | $74.72M | $27.69M | $74.54M | $113.81M |
| Dividends paid | $0.00 | $0.00 | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $38.62M | — | — | — | — |